Software S Sarah Constantin
AI Companies Are Not (Necessarily) Liable for Unintended AI Cyberattacks
I am not a lawyer, but this seems maybe important.
Software headlines from across biotech and life sciences, gathered from the industry press and linked straight to the publisher. Every story links straight to its publisher.
Software S Sarah Constantin
I am not a lawyer, but this seems maybe important.
Software A Asimov Press
Two of biology’s greatest theories completely predate direct experimental evidence. Tracing their origins could help us understand how to make the next ones.
Software M MetaphysicalCells
Frequent travel 🧳 for work conferences and meetings sounds glamorous 🪩 — until you’re juggling SIM cards 📲 and counting down layovers.
Software
Nature Biotechnology
Software
Nature Biotechnology
Software T This Week in Cheminformatics
RetroChimera, HDACiAP, and a long list of papers
Software T The Niche
What should the NIH budget be these days? Certainly higher than it is, but what would the ideal level be? One of my weekly reads is a proposal for $100B in NIH funding. All things considered, that seems reasonable to me. NIH is a massive engine of innovation for our country…
Software O Omics! Omics!
An interesting new approach to short read RNA-Seq library preparation bobbed into view this week, using click chemistry to barcode samples before any enzymatic processing. This bioorthogonal barcode sequencing approach - aka BOB-Seq - offers great promise in the burge…
Software
TechCrunch Biotech and Health
Blue Cross Blue Shield says hospital use of AI tools led to an additional $942 million in healthcare spending over a two-year period.
Software P Paired Ends
When the facts change, I change my mind. What do you do, sir?
Software
PharmaVoice
Nimbus Therapeutics’ head of R&D dishes on what’s next in AI-enabled drug discovery, years after Takeda completed its zasocitinib acquisition.
Software O Open Targets
Our September release contains a major increase in functional genomics data, notable updates in GWAS Catalog data and new sources of gene burden. Plus, updates from gnomAD add constraint information for X- and Y- linked chromosomes, data and engineering improvements, and a new me…
Software C ChEMBL-og
We are excited to announce that the new SureChEMBL's beta version is now out and can be accessed at: https://www.surechembl.org/beta/We’d love for you to try our new web interface and share your feedback. As we gradually move to the new web interface and APIs, we’re aiming to com…
Software
BioCentury
BIOCENTURY | EMERGING COMPANY PROFILENETWORK BIO: BUILDING DISEASE-SPECIFIC AI MODELS WITH BIOBANK DATAPalo Alto-based biotech identifying ‘barcodes’ from patient-derived tissues to model diseases over time for early detection and treatment
Software
Fierce Biotech
How AI-enabled predictive intelligence is becoming a new advantage in solid tumor drug development Explore how AI-enabled predictive intelligence can help oncology teams better understand tumor biology, sharpen development strategies and reduce uncertainty in solid tumor drug dev…
Software A Asimov Press
Biology is often seen as an experimental science, with theory serving to generalize patterns from empirical data. But history reveals that theory plays a more generative role in discovery itself.
Software T The Niche
Mitochondrial transfer is getting far more buzz these days. It can refer to different possible clinical applications or even just biological phenomena. A core translational idea here is that if you can replace diseased or malfunctioning mitochondria with new, healthier versions,…
Software B BLOPIG
Students new to programming may wonder why they even need to learn to code any more. They can ask the reasonable question: “Why can’t we just use AI for all our programming?” It’s a fair question. The Genie is out of the bottle. We aren’t putting it back. It absolutely does have…
Software
TechCrunch Biotech and Health
Zach Yadegari joins the Builders Stage at TechCrunch Disrupt 2026 to share how he capitalized on viral growth. Save up to $200 before September 25. Save 50% on a second pass.
Software
Fierce Biotech
AI-Powered CMC Authoring: Keep Your Dossier in Sync Discover how AI-powered CMC authoring can help keep Module 3 and the Quality Overall Summary aligned through every change. Download this free whitepaper to learn how a connected, evidence-based approach supports accuracy, consis…
Software
Fierce Pharma
AI-Powered CMC Authoring: Keep Your Dossier in Sync Discover how AI-powered CMC authoring can help keep Module 3 and the Quality Overall Summary aligned through every change. Download this free whitepaper to learn how a connected, evidence-based approach supports accuracy, consis…
Software C ChEMBL-og
@font-face {font-family:Wingdings; panose-1:5 0 0 0 0 0 0 0 0 0; mso-font-charset:0; mso-generic-font-family:auto; mso-font-pitch:auto; mso-font-signature:0 268435456 0 0 -2147483648 0;}@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-…
Software
BioSpace
While artificial intelligence can help biotech and pharma companies more quickly vet job applicants, it can also turn off the very people they want to employ. Two recruiting experts discuss AI’s role and limitations in the hiring process.
Software I In the Pipeline
I haven’t been sure what to make of the report that this Science piece is referring to. Anthropic says that it has blocked efforts to use its Claude AI systems for a number of undesirable functions, including possible design of bioweapons. One the one hand, it is unfortunately pl…
Software L Latch Bio
On the latest updates to our benchmark suite.
Software S Scaling Biotech
One thing I’ve been thinking a lot about lately, as I explore how the relationship between newer digital models and drug discovery teams has changed compared to previous waves of technology, is the increasing need to deliberately coordinate the evolution of the tools and the proc…
Software M Mac in Chem
mlxmolkit is a GPU-accelerated molecular toolkit using MLX on Apple Silicon, it is a port of nvMolKit that uses Cuda. It now includes Area What
Software E EMBL
A rebuilt InterProScan, InterPro-N predictions for your own sequences, a new Matches API and an MCP server bring faster, self-service and AI-ready protein classification
Software
Bio.News
BIO 2026 Start-Up Stadium winner generates human data to improve clinical translation. Artificial intelligence is opening new possibilities for drug discovery. But in neuroscience, […] The post BrainStorm Therapeutics combines brain organoids and AI for CNS drug discovery appeare…
Software W Weekly Tech+Bio
ALSO: Iambic files for a Nasdaq IPO into a rebounding market; Up to $1.4B for desining oral macrocycles with AI; Stanford researchers turn manuscripts into AI agents that collaborate, and more...
Software A Asimov Press
Pioneer Labs has made its first microbe capable of growing in simulated Martian soil and making building materials.
Software P Paired Ends
I got four minutes on live TV news to take on an important but nuanced topic.
Software M MetaphysicalCells
Kazmira Therapeutics is behind initiatives such as Kazmira Pharmacy and Cannabidiol API, and Cope Now a novel telehealth platform
Software J JEFworks
We recently developed an R package to perform spatial differential expression analysis called STcompare. The details of the method can be found in our paper in Oxford Bioinformatics. In our paper, we highlight how, given two spatial transcriptomics datasets to be compared such as…
Software
Owl Posting
3.8k words, 17 minutes reading time
Software A Applied Clinical Trials
Most AI pilots in drug development fail not from poor technology but from lack of strategic prioritization, organizational readiness, integrated data infrastructure, and disciplined governance, making success dependent on business discipline rather than technical capability.
Software P PLOS Biology
by Matthieu Marfoglia, Miguel A. Pedraza-Joya, Lucas Guirardel, Aisima Chatzi Souleiman, Patrick Barth Recent advances in artificial intelligence have transformed protein structure prediction and design. However, protein function is governed not only by static structures but also…
Software M Matt Gamber
CELC, IDYA, GERN, TGTX, HROW, MNKD, BBIO.
Software I Is life worth living?
Last week, I attended the 2026 RDKit UGM in person. It was really nice to meet other participants and have lots of discussions with them. All the oral presentations and poster presentations were great, and I was able to learn about a lot of cutting-edge work in cheminformatics. I…